Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Clinical Immunology (Orlando, Fla.)|April 2, 2020
Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primatesSarah Hughes, Justin Gumas, Rebecca Lee, et al.
Shock (Augusta, Ga.)|February 21, 2018
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic ShockMartijn van Griensven, Daniel Ricklin, Stephanie Denk, et al.
Nature Immunology|September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
C1q binding to surface-bound IgG is stabilized by C1r<sub>2</sub>s<sub>2</sub> proteasesSeline A Zwarthoff, Kevin Widmer, Annemarie Kuipers, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Clinical Immunology (Orlando, Fla.)|April 2, 2020
Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primatesSarah Hughes, Justin Gumas, Rebecca Lee, et al.
Shock (Augusta, Ga.)|February 21, 2018
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic ShockMartijn van Griensven, Daniel Ricklin, Stephanie Denk, et al.
Nature Immunology|September 29, 2019
'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Nature Immunology|October 13, 2019
Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug developmentDimitrios C Mastellos, Anna M Blom, E Sander Connolly, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2021
C1q binding to surface-bound IgG is stabilized by C1r<sub>2</sub>s<sub>2</sub> proteasesSeline A Zwarthoff, Kevin Widmer, Annemarie Kuipers, et al.
Pageof 14